6 September 2016
Fewer people are dying worldwide from ovarian cancer now than was the case a decade ago, according to new research.
Analysis led by the University of Milan has indicated that deaths from ovarian cancer fell globally between 2002 and 2012 and are predicted to continue to decline in the US, EU and Japan up to 2020.
In the EU, death rates decreased by ten percent between 2002 and 2012 from an age-standardised death rate of 5.76 per 100,000 women to 5.19 per 100,000. The range of variation between different countries also narrowed.
Professor Carlo La Vecchia from the faculty of medicine at the University of Milan, said the reduced variation in death rates across Europe "is likely to be due to more uniform use of oral contraceptives across the continent, as well as reproductive factors, such as how many children a woman has".
Oral contraceptives have been established as providing long-term protection against ovarian cancer, a trend that this research demonstrates.
In the US the decline was even greater, with a 16 per cent drop in death rates, although the the pattern of decreases was inconsistent in other areas of the world, including Latin America and some regions of Europe.
Posted by Jeanette Royston
Health News is provided by Axonn Media in collaboration with Spire Healthcare. Please note that all copy above is ©Axonn Media and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.